• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

ACS Sens . Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis

tetano

Editor, Senior Moderator
ACS Sens


. 2021 Jul 15.
doi: 10.1021/acssensors.1c00773. Online ahead of print.
Pulling-Force Spinning Top for Serum Separation Combined with Paper-Based Microfluidic Devices in COVID-19 ELISA Diagnosis


Fanwu Gong[SUP] 1 [/SUP], Hua-Xing Wei[SUP] 2 [/SUP], Ji Qi[SUP] 3 [/SUP], Huan Ma[SUP] 1 [/SUP], Lianxin Liu[SUP] 4 [/SUP], Jianping Weng[SUP] 5 [/SUP], Xucai Zheng[SUP] 1 [/SUP], Qiangsheng Li[SUP] 1 [/SUP], Dan Zhao[SUP] 1 [/SUP], Haopeng Fang[SUP] 1 [/SUP], Liu Liu[SUP] 1 [/SUP], Hongliang He[SUP] 2 [/SUP], Cuichen Ma[SUP] 1 [/SUP], Jinglong Han[SUP] 6 [/SUP], Anyuan Sun[SUP] 2 [/SUP], Baolong Wang[SUP] 2 [/SUP], Tengchuan Jin[SUP] 1 [/SUP], Bowei Li[SUP] 3 [/SUP], Bofeng Li[SUP] 1 [/SUP]



Affiliations

Abstract

The spread of Coronavirus disease 2019 (COVID-19) is caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), resulting in a global pandemic with around four million deaths. Although there are a variety of nucleic acid-based tests for detecting SARS-CoV-2, these methods have a relatively high cost and require expensive supporting equipment. To overcome these limitations and improve the efficiency of SARS-CoV-2 diagnosis, we developed a microfluidic platform that collected serum by a pulling-force spinning top and paper-based microfluidic enzyme-linked immunosorbent assay (ELISA) for quantitative IgA/IgM/IgG measurements in an instrument-free way. We further validated the paper-based microfluidic ELISA analysis of SARS-CoV-2 receptor-binding domain (RBD)-specific IgA/IgM/IgG antibodies from human blood samples as a good measurement with higher sensitivity compared with traditional IgM/IgG detection (99.7% vs 95.6%) for early illness onset patients. In conclusion, we provide an alternative solution for the diagnosis of SARS-CoV-2 in a portable manner by this smart integration of pulling-force spinning top and paper-based microfluidic immunoassay.

Keywords: COVID-19 diagnosis; SARS-Cov-2; anti-RBD antibody; microfluidic devices; paper-based ELISA; serum separation.
 
Back
Top Bottom